Amplicon details |
||
Amplicon: |
215 bp | |
1 ctcaccttgc tcctgccgag aaagtatcca tcatggctga tgcaatgcgg 51 cggctgcata cgcttgatcc ggctacctgc ccattcgacc accaagcgaa 101 acatcgcatc gagcgagcac gtactcggat ggaagccggt cttgtcgatc 151 aggatgatct ggacgaagag catcaggggc tcgcgccagc cgaactgttc 201 gccaggctca aggcg |
Record ID | Database | Record description | Record length | Taxon | Method | Amplicon size | Match details |
---|---|---|---|---|---|---|---|
HL997787.1 | emblrelpat | Sequence 15 from patent US 9453230. | 5049 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
HV192865.1 | emblrelpat | JP 2000509987-A/4: Variant fluoresc... | 6238 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
HV192885.1 | emblrelpat | JP 2000509987-A/24: Variant fluores... | 1521 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
HV192890.1 | emblrelpat | JP 2000509987-A/29: Variant fluores... | 1521 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
HV192893.1 | emblrelpat | JP 2000509987-A/32: Variant fluores... | 7617 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
HV196392.1 | emblrelpat | JP 2000513217-A/38: Gene expression... | 1003 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
HV196393.1 | emblrelpat | JP 2000513217-A/39: Gene expression... | 818 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
HV196782.1 | emblrelpat | JP 2000515494-A/34: Improved method... | 5703 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
HV201996.1 | emblrelpat | JP 2000189173-A/2: Expression cloni... | 9521 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
HV322336.1 | emblrelpat | JP 2011079835-A/1: Peptidomimetic P... | 900 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
HV341273.1 | emblrelpat | WO 2011058994-A/5: Animal models of... | 1516 bp | Transposon Tn5 | QL-ELE-00-002 | 215 bp | View |
HV539636.1 | emblrelpat | JP 2011200229-A/3: Improved Systems... | 8518 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
HV543299.1 | emblrelpat | JP 2011525808-A/54: ANTIBODY PRODUC... | 8188 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
HV758957.1 | emblrelpat | JP 2012508017-A/85: Anti-DLL4 Antib... | 5491 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
HV766719.1 | emblrelpat | WO 2012081628-A/19: Protein product... | 795 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
HV766736.1 | emblrelpat | WO 2012081629-A/6: Protein producti... | 795 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
HV816908.1 | emblrelpat | JP 2011078429-A/89: RECOMBINANT ALP... | 16656 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
HV960127.1 | emblrelpat | JP 2012197289-A/1: Peptidomimetic P... | 900 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
HW066935.1 | emblrelpat | JP 2013017442-A/1: Plasmid having a... | 11449 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
HW066936.1 | emblrelpat | JP 2013017442-A/2: Plasmid having a... | 12033 bp | unidentified | QL-ELE-00-002 | 215 bp | View |
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.